Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation

Huang,Haiyan; Xu,Xiaoguang; Yao,Chen; Cai,Ming; Qian,Yeyong; Wang,Xinying; Shi,Bingyi

doi:10.3892/mmr.2013.1753

Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation

Authors:
- Haiyan Huang
- Xiaoguang Xu
- Chen Yao
- Ming Cai
- Yeyong Qian
- Xinying Wang
- Bingyi Shi
View Affiliations

Affiliations: Organ Transplant Institute, Chinese PLA 309th Hospital, Beijing 100091, P.R. China
Published online on: October 23, 2013 https://doi.org/10.3892/mmr.2013.1753
Pages: 45-50

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The early diagnosis of acute rejection is crucial for graft survival after kidney transplantation. The interferon-γ (IFNγ)-CXCR3-chemokine-dependent inflammatory loop plays a pivotal role in the recruitment of T lymphocytes during acute rejection. Previously published studies have typically focused on the CXCR3 receptor rather than on its ligands. In the present study, we used Luminex assays to detect the levels of CXCR3 ligands, monokine induced by IFNγ (MIG), IFN-induced protein 10 (IP-10) and IFN-induced T‑cell chemoattractant (I-TAC), in the serum of renal allograft recipients. According to a renal biopsy performed one month after kidney transplantation, 32 recipients were diagnosed with T cell-mediated acute rejection and 38 patients were evaluated as stable. Serum was collected after the diagnosis of acute rejection or one month after transplantation. The concentrations of MIG (median, 4,271 pg/ml), IP-10 (median, 686.7 pg/ml) and I-TAC (median, 44.32 pg/ml) in the serum during an acute rejection episode were significantly higher compared with those of the stable patients (MIG, P=0.0002; IP-10, P=0.0001; I-TAC, P=0.0103; vs. the stable function group, P<0.05). Based on the receiver-operating characteristic (ROC) curve, the joint detection of MIG, IP-10 and I-TAC in the serum using Luminex analysis may constitute a non-invasive and efficient method for the early prediction of T cell-mediated acute rejection following kidney transplantation.

View Figures

View References

1	Matas AJ: Acute rejection is a major risk factor for chronic rejection. Transplant Proc. 30:1766–1768. 1998. View Article : Google Scholar : PubMed/NCBI
2	Gwinner W: Renal transplant rejection markers. World J Urol. 25:445–455. 2007. View Article : Google Scholar : PubMed/NCBI
3	Mihovilović K, Kardum-Skelin I, Ljubanović D, Sabljar-Matovinović M, Vidas Z and Knotek M: Urine immunocytology as a noninvasive diagnostic tool for acute kidney rejection: a single center experience. Coll Antropol. 34:63–67. 2010.PubMed/NCBI
4	Hollander Z, Lin D, Chen V, et al: Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy. Transplantation. 90:1388–1393. 2010. View Article : Google Scholar : PubMed/NCBI
5	Viklicky O, Hribova P, Volk HD, et al: Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol. 21:173–180. 2010. View Article : Google Scholar : PubMed/NCBI
6	Fahmy NM, Yamani MH, Starling RC, et al: Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation. 75:72–78. 2003. View Article : Google Scholar : PubMed/NCBI
7	Zhang Z, Kaptanoglu L, Tang Y, et al: IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology. 126:809–818. 2004. View Article : Google Scholar : PubMed/NCBI
8	Zerwes HG, Li J, Kovarik J, et al: The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats. Am J Transplant. 8:1604–1613. 2008. View Article : Google Scholar : PubMed/NCBI
9	Anders HJ, Vielhauer V and Schlöndorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 63:401–415. 2003. View Article : Google Scholar : PubMed/NCBI
10	Panzer U, Reinking RR, Steinmetz OM, et al: CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation. 78:1341–1350. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kanmaz T, Feng P, Torrealba J, et al: Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation. 78:1002–1007. 2004. View Article : Google Scholar : PubMed/NCBI
12	Wen X, Kudo T, Payne L, Wang X, Rodgers L and Suzuki Y: Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis. J Interferon Cytokine Res. 30:653–660. 2010.
13	McInnis KA, Britain A, Lausch RN and Oakes JE: Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are differentially regulated in human corneal keratocytes. Invest Ophthalmol Vis Sci. 46:1668–1674. 2005. View Article : Google Scholar : PubMed/NCBI
14	Campanella GS, Medoff BD, Manice LA, Colvin RA and Luster AD: Development of a novel chemokine-mediated in vivo T cell recruitment assay. J Immunol Methods. 331:127–139. 2008. View Article : Google Scholar : PubMed/NCBI
15	Bromley SK, Mempel TR and Luster AD: Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 9:970–980. 2008. View Article : Google Scholar : PubMed/NCBI
16	Solez K, Colvin RB, Racusen LC, et al: Banff ‘05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant. 7:518–526. 2007.
17	Han Y, Guo H, Xu YJ, et al: Pathological findings and clinical analyses on delayed renal graft function. SR Essays. 6:4744–4748. 2011.
18	Xu X, Huang H, Cai M, et al: Serum hematopoietic growth factors as diagnostic and prognostic markers of acute renal allograft rejection: a potential role for serum stem cell factor. Cytokine. 56:779–785. 2011. View Article : Google Scholar : PubMed/NCBI
19	Chen W, Pan X and Ni Z: Evaluation of 4 markers in the combining screening test for coronary heart disease. Mod Prev Med. 33:723–724. 2006.
20	Guo WH, Tian L, Chan KL, Dallman M and Tam PK: Role of CD4⁺ and CD8⁺ T cells in early and late acute rejection of small bowel allograft. J Pediatr Surg. 36:352–356. 2001.
21	Campanella GS, Tager AM, El Khoury JK, et al: Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA. 105:4814–4819. 2008. View Article : Google Scholar : PubMed/NCBI
22	Groom JR and Luster AD: CXCR3 in T cell function. Exp Cell Res. 317:620–631. 2011. View Article : Google Scholar
23	Ranjbaran H, Wang Y, Manes TD, et al: Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation. 114:1293–1300. 2006. View Article : Google Scholar : PubMed/NCBI
24	Seung E, Cho JL, Sparwasser T, Medoff BD and Luster AD: Inhibiting CXCR3-dependent CD8⁺ T cell trafficking enhances tolerance induction in a mouse model of lung rejection. J Immunol. 186:6830–6838. 2011.PubMed/NCBI
25	Christen U, McGavern DB, Luster AD, von Herrath MG and Oldstone MB: Among CXCR3 chemokines, IFN-gamma- inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol. 171:6838–6845. 2003. View Article : Google Scholar : PubMed/NCBI
26	Menke J, Zeller GC, Kikawada E, et al: CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol. 19:1177–1189. 2008. View Article : Google Scholar : PubMed/NCBI
27	Thapa M, Welner RS, Pelayo R and Carr DJ: CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol. 180:1098–1106. 2008. View Article : Google Scholar
28	Agostini C, Calabrese F, Rea F, et al: Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol. 158:1703–1711. 2001. View Article : Google Scholar : PubMed/NCBI
29	Romagnani PL, Lazzeri E, Lasagni L, et al: High expression of chemokines interferon-γ-inducible protein of 10 kDa (IP-10), monokine induced by interferon-γ-(Mig) and of their receptor (CXCR3) in acute renal rejection. Am J Transplant. 1:S3432001.
30	Inston NG and Cockwell P: The evolving role of chemokines and their receptors in acute allograft rejection. Nephrol Dial Transplant. 17:1374–1379. 2002. View Article : Google Scholar : PubMed/NCBI
31	Naidu BV, Krishnadasan B, Byrne K, et al: Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann Thorac Surg. 74:899–905. 2002. View Article : Google Scholar : PubMed/NCBI
32	Li J, Xia J, Zhang K and Xu L: Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. J Surg Res. 157:81–90. 2009. View Article : Google Scholar : PubMed/NCBI